2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer

Molecular Imaging and Biology

Volumn 4, Issue 3, 2002, Pages 257-263

  Nestle, Ursula ^a   Hellwig, Dirk ^a   Schmidt, Sylvia ^a   Licht, Norbert ^a   Walter, Karin ^a   Ukena, Dieter ^a   Rübe, Christian ^a   Baumann, Michael ^b   Kirsch, Carl Martin ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Elective nodal irradiation; ENI; FDG; GTV; Lung cancer; NSCLC; PET; Planning; Radiotherapy; Target volume

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SIZE; CANCER TISSUE; CAUSE OF DEATH; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; LUNG NON SMALL CELL CANCER; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RADIATION DOSE; THORAX CANCER; TREATMENT PLANNING;

EID: 0036292390     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1536-1632(02)00005-7     Document Type: Article

References (50)

1. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer
2. Continous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: Mature data from the randomised multicentre trial
3. Continous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial
4. CHARTWEL-Bronchus (ARO 97-1) Eine randomisiert multizentrische Studie zum Vergleich einer konventionell fraktionierten Strahlentherapie mit CHARTWEL-Bestrahlung bei inoperablen nichtkleinzelligen Bronchialkarzinomen
5. Modified fractionation in the radical treatment of non-small-cell lung cancer
6. Target volume definition for three-dimensional conformal radiation therapy of lung cancer
7. Dose escalation for non-small cell lung cancer using conformal radiation therapy
8. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s-meta-analytic comparison of PET and CT
9. Pre-operative staging of non-small-cell lung cancer with positron-emission tomography
10. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases
11. Analytical decision model for the cost-effective management of solitary pulmonary nodules
12. 18F-fluoro-deoxyglucose positron emission tomographic imaging to radiotherapy planning in lung cancer
13. 18-F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis
14. Multimodality nuclear medicine imaging in radiation treatment planning for lung cancer: Challenges and prospects
15. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: Preliminary findings
16. The impact of 18-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
17. CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
18. Dose escalation of chart in non-small cell lung cancer: Is three-dimensional conformal radiation therapy really necessary?
19. Improved survival of patients with unresectable non-small cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach
20. Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation
21. Counterpoint: The potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer
22. 18FDG PET scans
23. Clinical applications of fusion imaging in oncology
24. Intermodality, retrospective image registration in the thorax
25. Internal commission on radiation units and measurements (ICRU) Report 50: Prescribing, recording, and reporting photon beam therapy
26. Internal Commission on radiation units and measurements (ICRU) Report 62: Prescribing, recording and reporting photon beam therapy
27. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma
28. Grundlagen und Ergebnisse der systematischen Lymph-knotendissektion beim operierten Bronchialkarzinom
29. New aspects in the staging of lung cancer
30. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the radiologic diagnostic oncology group
31. Role of cervical mediastinoscopy in staging of non-small-cell lung cancer without enlarged mediastinal lymph nodes on CT-scan
32. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis
33. The current role of mediastinoscopy in the evaluation of thoracic disease
34. Surgical exploration of the mediastinum by mediastinoscopy, parasternal mediastinotomy and remediastinoscopy: Indications, technique and complications
35. The role of surgery in N2 lung cancer
36. Lymph node mapping and curability at various levels of metastasis in resected lung cancer
37. Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of staging
38. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus
39. Surgery for non-small cell lung cancer
40. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung
41. Lung
42. Controversies in the nonsurgical treatment of stage III non-small cell lung cancer
43. Radiation injury to the heart
44. Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems
45. Late effects of radiation therapy on the gastrointestinal tract
46. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer
47. Quantification of radiation-induced regional lung injury with perfusion imaging
48. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiotherapy (3D-CRT)
49. Incidental dose to clinically negative nodes from conformal treatment fields for non-small cell lung cancer
50. Intratumoral distribution of F-18 Fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography